Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT00371488

Completed

GW572016 Combined With Trastuzumab For The Treatment Of Previously Trastuzumab-Treated Breast Cancer

Neoplasms, Breast
NCT02988648

Withdrawn

A Clinical Trial Evaluating the Safety and Clinical Activity of Radioiodide (131I-) as a Novel Targeted Therapy for Metastatic Breast Cancer That Overexpresses Functional Na/I Symporter

Breast Cancer
NCT00759785

Completed

A Study of Dalotuzumab (MK-0646) in Breast Cancer Patients (MK-0646-013)

Breast Cancer
NCT00088972

Terminated

S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women

Breast Cancer
NCT03289286

Completed

Pilot Study Evaluating a Perioperative E-follow-up Protocol in Patients With Ambulatory Surgery for Breast Cancer (PITCA)

Breast Cancer
NCT02316561

Completed

Single Dose Ablative Radiation Treatment for Early-Stage Breast Cancer (ABLATIVE)

Breast Neoplasm
NCT02372305

Withdrawn

Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery

Breast Neoplasm
NCT02455882

Terminated

Tissue Procurement Protocol for Patients Undergoing Treatment for Early-Stage Breast Cancer

Breast Cancer
NCT01501487

Completed

MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I (MINT)

Breast Cancer
NCT03296683

Unknown

Evaluation of a 3D Functional Metabolic Imaging and Risk Assessment System in Classifying Women for Likelihood of Breast Cancer

Breast Cancer
NCT01626144

Completed

Metabolizing Enzyme Genotype Versus Exemestane Metabolism Profiles

Breast Cancer
NCT02273973

Completed

A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)

Breast Cancer
NCT00897468

Completed

Developing Mouse Models of Breast Cancer Using Tissue Samples From Women With Breast Cancer

Breast Cancer
NCT03507465

Unknown

Letrozole Plus Low-Dose Metronomic Capecitabine Versus EC-T (Epirubicin/Cyclophosphamide Followed by Docetaxel) as Neoadjuvant Therapy for ER+/HER2-negative Breast Cancer

Breast Cancer
NCT00944047

Completed

Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression

Breast Cancer
NCT02914197

Unknown

Giving Information on the Risks and Limitations of Mammography Screening (GIRLS) (GIRLS)

Breast Neoplasm
NCT01010854

Terminated

Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Breast Cancer (VPA-FEC100)

Breast Cancer
NCT00256243

Completed

Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast Cancer

Breast Cancer
NCT02596867

Terminated

Neoadjuvant Propanolol in Breast Cancer (NPBC)

Breast Cancer
NCT02688257

Completed

Assessing Treatment Response in Breast Cancer With Functional Imaging

Breast Cancer
NCT03442543

Unknown

Preoperative Localization of Sentinel Lymph Node in Breast Cancer Patients By Novel Computed Tomography-Lymphography Guided Technique

Breast Cancer
NCT01698281

Terminated

Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer

Breast Cancer
NCT01817374

Terminated

Breast VCEUS to Evaluate Early Response to Neoadjuvant Chemotherapy

Breast Cancer
NCT01972048

Withdrawn

Mobile Phone Multimedia Messaging Intervention for Breast Cancer Screening

Breast Cancer
NCT00882089

Completed

Use of the Contura™ Catheter in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer Patients

Breast Cancer
NCT00873366

Terminated

Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer

Breast Cancer
NCT02882581

Completed

Metformin in Breast Cancer, Visualized With Positron Emission Tomography

Breast Cancer
NCT02783222

Completed

EFficacy and Impact on Function of Two Different Doses of Nab-paclitaxEl in Elderly With advanCed breasT Cancer (EFFECT)

Breast Cancer
NCT00201760

Completed

Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer

Breast Cancer
NCT00003830

Completed

Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer

Breast Cancer
NCT01771666

Completed

Pilot Indocyanine Green Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast Cancer

Breast Cancer
NCT01425294

Terminated

Collection of Efficacy and Safety Data of Chinese Patients Who Have Received Faslodex 250mg Treatment

Breast Cancer
NCT00388076

Completed

Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB)

Neoplasms, Breast
NCT01669239

Completed

Study of Neoadjuvant Myocet®, Paclitaxel, Pertuzumab, and Trastuzumab in HER2-positive Breast Cancer (Opti-HER)

Breast Cancer
NCT01508572

Completed

VEGF-targeted Fluorescent Tracer Imaging in Breast Cancer

Breast Cancer
NCT03319511

Completed

Thoracic Spinal Anesthesia in Awake Breast Surgery

Breast Cancer
NCT02483767

Completed

Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer (POF)

Breast Cancer
NCT03108937

Completed

Effects of Dexmedetomidine on Breast Cancer Cell Function in Vitro

Breast Cancer
NCT00519168

Completed

Sleep, Circadian Hormonal Dysregulation, and Breast Cancer Survival

Breast Cancer
NCT00976339

Completed

Study of Vitamin D for Premenopausal Women at High Risk for Breast Cancer

Breast Cancer
NCT00684216

Terminated

Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer

Breast Cancer
NCT01918254

Completed

A Study to Evaluate Lumretuzumab in Combination With Pertuzumab and Paclitaxel in Participants With Metastatic Breast Cancer Expressing Human Epidermal Growth Factor Receptor (HER) 3 and HER2 Protein

Breast Cancer
NCT03275727

Unknown

A Guided Internet-delivered Individually-tailored ACT-influenced CBT Intervention to Improve Psychosocial Outcomes in Breast Cancer (INNOVBC)

Breast Neoplasm
NCT03273595

Unknown

Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive Breast Cancer

Neoplasms, Breast
NCT03273348

Unknown

Role of Oncoplastic Breast Surgery In Breast Cancer Treatement

Breast Cancer
NCT01275859

Completed

Neoadjuvant Combined Endocrine and HER2 Target Therapy in Postmenopausal Women With ER and Her2 Positive Breast Cancer (Neo-All-In)

Breast Cancer
NCT02001506

Completed

Neoadjuvant Chemotherapy of 6 Cycles vs 8 Cycles in Node Positve Breast Cancer (Neo-shorter)

Breast Cancer
NCT03255486

Completed

Identification and Evaluation of Biomarkers of Resistance to Neoadjuvant Chemotherapy (IDEA SEIN) (IDEASEIN)

Breast Cancer
NCT00870415

Completed

Breast-Conserving Surgery Techniques in Treating Women With Breast Cancer

Breast Cancer
NCT02360059

Terminated

Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer

Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations